DobbieJ.W., and ZakiM.A.The ultrastructure of the parietal peritoneum in normal and uremic man and in patients on CAPD. In: MaherJ.F., and WinchesterJ.F., eds. Frontiers in peritoneal dialysis.New York: Field and Rich, 1985: 105–7.
4.
DobbieJ.W., HendersonI.S., WilsonL.S.New evidence on the pathogenesis of sclerosing encapsulating peritonitis (SEP) obtained from serial biopsies. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in continuous ambulatory peritoneal dialysis.Toronto: University of Toronto Press, 1987; 3: 138–49.
5.
DobbieJ.W.The morphology of the peritoneum in CAPD.Blood Purif1989; 7: 74–85.
6.
DobbieJ.W., LloydJ.K., GallC.A.Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: University of Toronto Press1990; 6: 3–12.
7.
DobbieJ.W.Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.Perit Dial Int1992; 12: 14–27.
8.
DobbieJ.W.Surgical peritonitis: its relevance to the pathogenesis of peritonitis in CAPD.Perit Dial Int1988; 8: 241–8.
9.
PorterK.R., Hawn C vanX.Sequence in the formation of clots from purified fibrinogen and thrombin: a study with electron microscope.J Exp Med1949; 90: 225–31.
10.
LinC.Y., WallenP., HandleyD.A.The structural, functional and genetic defects and an hypothesis of the role offibrin in the regulation of coagulation and fibrinolysis. In: LaneD.A., HenschenA., J asaniM.K., eds. Fibrinogen, fibrin formation and fibrinolysis. Vol. 4, Berlin: Walter de Gruyter, 1986: 79–90.
11.
PrydzH.Triggering of the intrinsic blood coagulation pathway. In: LaneD.A., HenschenA., JasaniM.K., eds. Fibrinogen, fibrin formation and fibrinolysis. Vol. 4, Berlin: Walter de Gruyter, 1986: 325–35.
12.
LybergT., PrydzH., BalkienK.Effect of immune complex-containing sera from patients with rheumatic diseases on thromboplastin activity of monocytes.Thromb Res1982; 25: 193–202.
ParonettoF., BorelY., MiescherA.Localisation of complement immunoglobulins and fibrinogen in skin sites of tuberculin reaction, passive cutaneous anaphylaxis and Arthus reaction. In: MiescherP.A., GraberP., eds. Immunopathology. Vth International Symposium.New York: Grune & Stratton, 1967: 317–24.
15.
TalbotM.D., PetersR.F., TweedM.F.Extravascular fibrin deposition in cellular hypersensitivity -the role of T-lymphocyte macrophage interactions. In: LaneD.A., HenschenA., JasaniM.K., eds. Fibrinogen, fibrin formation and fibrinolysis. Vol. 4, Berlin: Walter de Gruyter, 1986: 347–55.
16.
PetersR.F., JasaniM.K., TweedM.F., KnightI., LaneD.A.Extravascular fibrin formation and fibrinolysis in a model of inflammation accompanying cellular hypersensitivity. In: LaneD.A., HenschenA., JasaniM.K., eds. Fibrinogen, fibrin formation and fibrinolysis. Vol. 4, Berlin: Walter de Gruyter, 1986: 337–45.
17.
BullockG.R., ChristmasS.E., JasaniM.K.Lymphocytes, inflammation and fibrin studies in an experimental foot-pad oedema model of the Koch phenomenon.Br J Pharmacol1983; 79: 240P.
18.
ChristmasS.E., JasaniM.K., JaysonM.I.V.The effects of immunosuppression and anticoagulation on fibrin deposition in cardiac allografts.Clin Immunol Immunopathol1987; 42: 18–26.
19.
BachC.S., JasaniM.K.Role of lymphocytes in accumulation offibrin in rabbit skin homografts.BrJ Pharmacol1978; 58: 292P.
20.
JasaniM.K.Fibrin: Metabolism, immunopathogenesis and significance in rheumatoid arthritis. In: PanayiG.S., JohnsonP.M., eds. Immunopathogenesis of rheumatoidarthritis.Chertsey, U.K.: ReedBooks, 1979: 137–46.
21.
GustavssonE., BlombackB., BlombackM.Plasmin in the prevention of adhesions.Acta Chir Scand1955; 109: 327–33.
22.
KnightlyJ.J., AgostinoD., ClifftonE.E.The effect of fibrinolysin and heparin on the formation of peritoneal adhesions.Surgery1962; 52: 250–8.
23.
PorterJ.M., McGregorF.H., MullenD.C.Fibrinolytic activity of mesothelial surfaces.Surg Forum1969; 20: 80–2.
24.
WhitakerD., PapadimitrouJ.M., WaltersM.The mesothelium: its fibrinolytic properties.J Pathol1982; 136: 291–9.
25.
GervinA.S., PuckettC.L., SilverD.Serosal hypofibrinolysis. A cause of post-operative adhesions.Am J Surg1973; 125: 80–8.
26.
BuckmanR.F., WoodsM., SargentL., GervinA.S.A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions.J Surg Res1976; 20: 1–5.
27.
RafteryA.T.Regeneration of peritoneum: a fibrinolytic study.J Anat1979; 129: 659–63.
Myhre-JensenO., LarsenS.B., AstrupT.Fibrinolytic activity in serosal and synovial membranesArch Pathol1969; 88: 623–30.
33.
AhrenholzD.H., SimmonsR.L.Fibrin in peritonitis. Part I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis.Surgery1980; 88: 41–7.
34.
BosworthN., ArtherG.T.The eosinophil content of the peritoneal cavity of the rat.Aust J Exp Biol Med Sci1961; 39: 165–70.
35.
GleichG.J., LoegeringD.Selective stimulation and purification of eosinophils and neutrophils from guinea pig peritoneal fluids.J Lab Clin Med1973; 82: 522.
36.
LindorL.J., LoegeringD.A., WassomD.L., GleichG.J.Recovery of eosinophils from the peritoneal cavity of the guinea pig.JImmunol Methods1981; 41: 125–34.
37.
DobbieJ.W.Serositis: comparative analysis of histological findings and pathogenetic mechanisms in nonbacterial serosal inflammation.Perit Dial Int1993; 13: 256–9.
38.
GoeddeM., SitterT., SchifflH.Coagulation and fibrinolysis related antigens in plasma and dialysate of CAPD patients.Perit Dial Int1997; 17: 162–6.
39.
GoudieR.V.Molecular and cellular pathology of tissue damage. In: AndersonJ.R., ed. Muir's textbook of pathology. 12th ed. Vol. 4, London: Edward Arnold, 1987: 9–22.
40.
TragerM.Current views on the mechanisms of coagulase action in blood clotting.Ann N Y Acad Sci1974; 236: 277–91.